Sabby Management’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,235
| Closed | -$48K | – | 98 |
|
|
2021
Q4 | $48K | Buy |
+1,235
| New | +$48K | 0.01% | 95 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 105 |
|
|
2021
Q2 | – | Sell |
-12,560
| Closed | -$559K | – | 95 |
|
|
2021
Q1 | $559K | Buy |
+12,560
| New | +$559K | 0.11% | 52 |
|
|
2020
Q4 | – | Sell |
-3,548
| Closed | -$92K | – | 70 |
|
|
2020
Q3 | $92K | Buy |
+3,548
| New | +$92K | 0.01% | 63 |
|
|
2020
Q2 | – | Sell |
-54,171
| Closed | -$813K | – | 59 |
|
|
2020
Q1 | $813K | Buy |
+54,171
| New | +$813K | 0.34% | 11 |
|
|
2019
Q4 | – | Sell |
-33,817
| Closed | -$640K | – | 57 |
|
|
2019
Q3 | $640K | Buy |
+33,817
| New | +$640K | 0.34% | 16 |
|
|
2019
Q1 | – | Sell |
-1,122
| Closed | -$29K | – | 63 |
|
|
2018
Q4 | $29K | Buy |
1,122
+659
| +142% | +$17K | 0.01% | 72 |
|
|
2018
Q3 | $20K | Sell |
463
-15,824
| -97% | -$684K | ﹤0.01% | 70 |
|
|
2018
Q2 | $937K | Sell |
16,287
-9,361
| -36% | -$539K | 0.14% | 28 |
|
|
2018
Q1 | $1.99M | Buy |
25,648
+17,243
| +205% | +$1.34M | 0.24% | 9 |
|
|
2017
Q4 | $820K | Buy |
+8,405
| New | +$820K | 0.07% | 29 |
|